Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Do you offer hypofractionation or RNI for a pT1N0 high-grade primary neuroendocrine carcinoma of the breast?
Answer from: Radiation Oncologist at Community Practice
Hypofractionation with a boost, yes. No RNI if the SNLN is negative.
Sign In
or
Register
to read more
30923
Related Questions
What are your top takeaways in Breast Cancer from ESMO 2025?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
Is stage I B/L breast, ER+ cancer a contraindication to breast radiation omission after breast conservation surgery?
How do you optimally set a patient up for breast radiation therapy if you don't have access to a breast board or wing board?
Have the 10-year results from UK FAST-Forward presented at ESTRO 2025 impacted your practice with regard to patient selection?
How would you treat a schwannoma of the breast with a positive margin that is not amenable to re-excision?
Would you offer ultrahypofractionated 5-fraction whole breast only for a women with ER-/HER2+/cN+ disease with pCR following neoadjuvant systemic therapy?
Does a high genomic risk score impact your radiation fields for patients with breast cancer?
What is your approach to women with breast cancer who opts for a staged approach with up-front lumpectomy and SLN biopsy (pN-) when there are indications for adjuvant radiation therapy but she plans for a later mastectomy (=>6 months)?
What are your top takeaways in Breast Cancer from ASCO 2025?